摘要
随着介入诊疗技术及现代影像学的发展,临床对比剂用量日益增多,随之而来的对比剂肾病逐渐引起临床医师关注,已成为医源性急性肾衰竭重要原因之一.由于对比剂肾病除部分患者表现为少尿性肾衰竭外,多数患者无明显临床症状,故不易早期发现.现就对比剂肾病研究进展综述如下.
出处
《中国医师进修杂志》
2015年第5期385-387,共3页
Chinese Journal of Postgraduates of Medicine
参考文献26
-
1Stacul F,van der Molen AJ,Reimer P,et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines [ J ]. Eur Radiol, 2011,21 ( 12 ) : 2527-2541.
-
2贺建勋,吴小慧,袁慧.胱蛋白酶抑制素C对冠心病合并肾功能不全患者对比剂对早期肾功能影响的研究[J].心肺血管病杂志,2014,33(1):64-68. 被引量:6
-
3Inker LA,Schmid CH,Tighiouart H,et al. Estimating glomerular filtration rate from serum creatinine and cystatin C [J]. N Engl J Med,2012,367( 1 ) :20-29.
-
4Levine GN,Bates ER,Blankenship JC, et al. 2011 ACCF/ AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions [J]. J Am Coll Cardiol,2011,58(24) : e44-122.
-
5Maioli M ,Toso A, Leoncini M ,et al. Persistent renal damage after contrast-induced acute kidney injury:incidence,evolution,risk factors,and prognosis[J]. Circulation, 2012,125(25):3099-3107.
-
6Aspelin P,Aubry P,Fransson SG,et al. Nephrotoxic effects in high- risk patients undergoing angiography [ J ]. N Engl J Med, 2003,348 (6) :491-499.
-
7G ti 1 M, Turan B, Uur M, et al. Nephrotoxicity of iodixanol versus iopamidol in patients with acute coronary syndrome [J]. Turk Kardiyol Dern Ars, 2013,41 ( 1 ) : 21-27.
-
8Becker J, Babb J, Serrano M. Glomerular filtration rate in evaluation of the effect of iodinated contrast media on renal function [ J ]. A JR Am J Roentgenol, 2013,200(4) : 822-826.
-
9Lenhard DC, Frisk AL, Lengsfeld P, et al. The effect of iodinated contrast agent properties on renal kinetics and oxygenation [J]. Invest Radiol, 2013,48 (4) : 175-182.
-
10Kagan A,Sheikh-Hamad D. Contrast-induced kidney injury:focus on modifiable risk factors and prophylactic strategies [J]. Clin Cardiol, 2010,33 ( 2 ) : 62-66.
二级参考文献11
-
1Nash KA, Hafeez A, Hou S. Hospital-acquired renal insufficien- cy. Am J Kidney Dis, 2002,39 : 930-936.
-
2Ma YC, Zuo L, Chen JH, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soe Nephrol, 2006, 17: 2937-2944.
-
3Solomon R, Barrett B. Follow-up of patients with contrast-in- duced nephropathy. Kidney Int Suppl, 2006: $46-50.
-
4Tomlanovieh, SH, Golbetz M, Perlroth E, et al. Myers, Limita- tions of creatinine in quantifying the severity of cyelosporine-in- duced chronic nephropathy. Am J Kidney Dis, 1986,8: 332- 337.
-
5Newhouse JH, Kho D, Rao QA, et al. Starren, frequency of ser- um creatinine changes in the absence of iodinated contrast materi- al: implications for studies of contrast nephrotoxicity. AJR, 2008, 191 : 376-382.
-
6Star RA. Treatment of acute renal failure. Kidney Int, 1998, 54: 1817-1831.
-
7Venkataraman R, Kellum JA. Defining acute renal failure: the RIFLE criteria. J Intensive Care Med, 2007, 22: 187-193.
-
8Trof R J, Maggio FD, Leemreis J, et al. Groeneveld, Biomark- ers of acute renal injury and renal failure. Shock, 2006. 26: 245-253.
-
9Royakkers AA, Van Suijlen LS. Hofstra MA, et al. Schultz, Se- rum cystatin C-A useful endogenous marker of renal function in intensive care unit patients at risk for or with acute renal failure.9 Curr Med Chem, 2007, 14: 2314-2317.
-
10McCullough PA, Contrast-induced acute kidney injury. J Am Coil Cardiol, 2008, 51 : 1419-1428.
共引文献5
-
1彭莉,黄嘉南,赵崇亮,谭冠昶,禤伟振,陶涛,萧浤.胱抑素C在经皮冠状动脉介入治疗术后造影剂肾病诊断中的价值[J].中华内科杂志,2015,54(3):188-192. 被引量:20
-
2余德龙,顾晔,胡利群.血管内超声与冠状动脉造影指导冠状动脉支架置入术对比分析[J].中外医疗,2016,35(8):187-188.
-
3张瑶,田祥,耿巍,张旗,甄利波,刘倩梅,杨颖,宋达.胱抑素C对对比剂肾病的预测价值[J].临床荟萃,2016,31(7):770-773. 被引量:2
-
4徐增政,高亚平.高敏C反应蛋白对对比剂肾病的预测价值[J].心血管病防治知识(学术版),2017,7(12):58-60.
-
5黄万众,陈瑜,李维,顾娜,秦艳,陆丽娟.胱抑素C在老年患者低剂量造影剂肾病中的预测价值[J].广西医学,2019,41(2):157-160. 被引量:4
同被引文献22
-
1Mehran R, Aymong ED, Niknlsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation[J]. J Am Coll Cardiol, 2004, 44 ( 7 ) :1393-1399.
-
2高瑞雪.不同年龄冠状动脉介入术后患者水化治疗预防造影剂肾病效果观察[J].护理学杂志(综合版),2009,24(9):25-27. 被引量:15
-
3周圣华,卢才义,翟金月,张玉霄,颜伟,薛桥,高磊,李丽君,赵忠仁.围手术期补液速度对冠心病患者支架置入后血小板聚集率的影响[J].中国介入心脏病学杂志,2010,18(2):69-72. 被引量:6
-
4陈健红,朱春梅,邓瑞珍.不同饮水法对心脏介入治疗患者造影剂相关性肾损伤的影响[J].护理学报,2010,17(15):35-37. 被引量:26
-
5郁华.心脏介入手术前水化对造影剂肾病发生的影响[J].中国医疗前沿,2011,6(9):29-29. 被引量:5
-
6刘文娟,夏勇,沈莹.改进水化方案预防对比剂肾病的效果[J].中华现代护理杂志,2013,19(18):2117-2121. 被引量:3
-
7唐菊娣.不同水化疗法预防心力衰竭患者冠脉介入术后对比剂肾病的效果[J].护理实践与研究,2013,10(20):55-56. 被引量:4
-
8唐陆秀,汤一君,钱华英,杨意念.水化疗法对预防慢性肾病患者造影剂肾病的护理[J].实用临床医药杂志,2014,18(4):9-11. 被引量:10
-
9中华医学会放射学分会,金征宇.头颈部CT血管成像扫描方案与注射方案专家共识[J].中华放射学杂志,2019,53(2):81-87. 被引量:53
-
10曹希明,郑君惠,巫梓斌,钟小梅,李新云.低剂量对比剂在256层CT头颈血管成像中的应用[J].中国医学影像学杂志,2017,25(2):101-104. 被引量:21
引证文献2
-
1过庆华,曹文君,赵晓倩.PCI水化治疗的护理[J].医疗装备,2016,29(11):196-197. 被引量:3
-
2韦婷,成肇杰,梁卫学,刘光明,王占宇.低剂量对比剂结合静脉团注追踪法在鼻咽癌放疗定位中的应用[J].中华放射肿瘤学杂志,2024,33(1):7-12.
二级引证文献3
-
1马益敏,肖玲,傅荣春,王海霞.优化护理在TACE术水化治疗预防对比剂肾病中的效果观察[J].实用临床医药杂志,2017,21(20):165-166. 被引量:6
-
2卞粲,章亚平.预防冠脉介入治疗中造影剂引起的急性肾功能损伤的研究进展[J].护士进修杂志,2019,34(4):318-322. 被引量:8
-
3刘明珠,梁兜选,梁爱红.水化治疗双版提示卡在冠状动脉介入治疗术老年病人中的应用研究[J].全科护理,2019,17(33):4171-4173. 被引量:2
-
1王伟杰,姜彩霞,朴香月,尹龙.腹膜透析治疗肾综合征出血热少尿性肾功衰竭6例分析[J].吉林医学,1999,20(1):48-49.
-
2段立斌.介入诊疗技术在临床上的应用价值[J].中国社区医师(医学专业),2012,14(7):171-171.
-
3苏丽萍,郑文娴,黄孔阳,傅声帆,王谊.无骨折脱位型颈髓损伤的围手术期护理56例[J].中国实用护理杂志,2005,21(2):41-42. 被引量:14
-
4陈誉,李明.颈椎损伤的影像学诊断:回顾与展望[J].创伤外科杂志,2012,14(1):93-96. 被引量:3
-
5潘伟波,梁军波,陈海啸.AO微型钢板治疗跖骨骨折[J].浙江创伤外科,2008,13(3):231-231. 被引量:2
-
6毛宾尧.正确把握腰椎间盘突出髓核摘除后椎间融合问题[J].中国矫形外科杂志,2007,15(15):1198-1198. 被引量:4
-
7任庆华.1例无骨折脱位型颈髓损伤并完全性瘫围手术期的护理[J].丹东医药,2007(1):57-58. 被引量:1
-
8金征宇,李晓光.介入诊疗技术在肾功能衰竭患者中的应用[J].医学研究通讯,2004,33(7):3-4.
-
9罗萍,孙晶,卢雪虹,孙广东,丛森.急性少尿性肾功能衰竭与表皮生长因子含量表达[J].吉林医学,1998,19(4):206-207.
-
10庄永泽,郑智勇,陈建,张河震.高尿酸血症、双肾肿大、非少尿性急性肾衰[J].实用医学杂志,2004,20(8):973-975. 被引量:1